Exagen Inc.
XGN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $17 | $17 | $15 | $14 |
| % Growth | 0.2% | 11% | 13.5% | – |
| Cost of Goods Sold | $7 | $7 | $6 | $5 |
| Gross Profit | $10 | $10 | $9 | $8 |
| % Margin | 58.4% | 60.4% | 58.9% | 62.1% |
| R&D Expenses | $2 | $1 | $1 | $2 |
| G&A Expenses | $0 | $0 | $0 | $10 |
| SG&A Expenses | $11 | $12 | $11 | $10 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $13 | $13 | $12 | $12 |
| Operating Income | -$3 | -$3 | -$3 | -$3 |
| % Margin | -18% | -15.3% | -21.7% | -24.8% |
| Other Income/Exp. Net | -$4 | -$2 | -$0 | -$0 |
| Pre-Tax Income | -$7 | -$4 | -$4 | -$4 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$7 | -$4 | -$4 | -$4 |
| % Margin | -41.1% | -25.8% | -24.2% | -27.5% |
| EPS | -0.31 | -0.21 | -0.2 | -0.2 |
| % Growth | -47.6% | -5% | 0% | – |
| EPS Diluted | -0.31 | -0.21 | -0.2 | -0.2 |
| Weighted Avg Shares Out | 23 | 21 | 19 | 18 |
| Weighted Avg Shares Out Dil | 23 | 21 | 19 | 18 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1 | $1 | $1 | $1 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$5 | -$3 | -$3 | -$3 |
| % Margin | -30.8% | -16.3% | -17.9% | -20.3% |